Rheumatology

Uzm. Dr. Emin Oğuz

Doctor and researcher Medipol Bahçelievler Üniversite Hastanesi İstanbul
İngilizce
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

CV

Education and experience

From source

Experience

  • 2024 - 2025İstinye Üniversitesi Bahçeşehir Hastanesimedipol.com.tr
  • 2019 - 2024Van Bölge Eğitim ve Araştırma Hastanesimedipol.com.tr
  • 2014 - 2014Silopi Devlet Hastanesimedipol.com.tr
  • 2007 - 2008Van Devlet Hastanesimedipol.com.tr

Education

  • 2018İstanbul Üniversitesi İstanbul Tıp Fakültesi, Romatolojimedipol.com.tr
  • 2014İstanbul Üniversitesi İstanbul Tıp Fakültesi, İç Hastalıklarımedipol.com.tr
  • 2014İstanbul Üniversitesi İstanbul Tıp Fakültesi, İç Hastalıkalrımedipol.com.tr
  • 2010Atatürk Üniversitesi Tıp Fakültesi, Kardiyoloji -Araştırma Görevlisimedipol.com.tr
  • 2007Uludağ Üniversitesi, Tıp Fakültesimedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRheumatologymedipol.com.trFrom source
  • InstitutionMedipol Bahçelievler Üniversite Hastanesimedipol.com.trFrom source
  • Publications13 publicationsmedipol.com.tr profile pageFrom source
  • Languagesİngilizcemedipol.com.trFrom source
  • Last synchronised4 November 2026 20:20https://medipol.com.tr/doktorlarimiz/uzmdr-emin-oguzmedipol.com.tr

Scientific work

Publications

13 publications

  1. 1. Oğuz E, Bektaş M. Characteristics of patients with Behçet disease from the Van province, eastern Turkey: Definition of disease clusters in a tertiary referral center. J Clin Rheumatol. 2023. doi:10.1097/RHU.0000000000001996

    Source: medipol.com.tr profile page

  2. 2. Oğuz E, et al. Characteristics and course of patients with AA amyloidosis: Single centre experience with 174 patients from Turkey. Rheumatology (Oxford). 2024;63(2):319-328. doi:10.1093/rheumatology/kead465

    Source: medipol.com.tr profile page

  3. 3. Oğuz E, et al. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: A controlled study. Clin Exp Rheumatol. 2024;42(2):358-366. doi:10.55563/clinexprheumatol/9u122p

    Source: medipol.com.tr profile page

  4. 4. Bektaş M, Özer MD, Oğuz E. The safety and efficacy of TNF inhibitors in patients with Behçet’s disease: Retrospective study from eastern Turkey. Clin Immunol. 2024;264:110239. doi:10.1016/j.clim.2024.110239

    Source: medipol.com.tr profile page

  5. 5. Oğuz E, Koca N, Bektaş M. Presence of myositis-specific autoantibodies may predict favorable outcomes to rituximab in patients with idiopathic inflammatory myositis: Retrospective observational study. Mod Rheumatol. 2025 (ahead of print). doi:10.1093/mr/roaf097

    Source: medipol.com.tr profile page

  6. 6. Oğuz E, et al. Chronic oxcarbazepine intoxication in a patient with primary antiphospholipid syndrome on maintenance haemodialysis. J Clin Pharm Ther. 2022;47(2):257-259. doi:10.1111/jcpt.13504

    Source: medipol.com.tr profile page

  7. 7. Oğuz E, et al. Activation-induced cytidine deaminase expression in patients with chronic myeloid leukemia Experimed. 2022;12(3):155-159

    Source: medipol.com.tr profile page

  8. 8. Oğuz E, et al. Üçüncü basamak bir hastanede takip edilen COVID-19 olgularında immünosüpresif tedavi uygulanan hastaların değerlendirilmesi. Klimik Dergisi. 2022

    Source: medipol.com.tr profile page

  9. ULUSLARARASI KONGRE SUNUMLARI (ACR)

    Source: medipol.com.tr profile page

  10. 9. Oğuz E, et al. Classification of idiopathic inflammatory myopathies: Assessment according to 2017 ACR/EULAR criteria. Arthritis Rheumatol. 2018;70(Suppl 9)

    Source: medipol.com.tr profile page

View all 13 publications